Opko Health (OPK) Cost of Revenue (2010 - 2026)

Opko Health (OPK) has 17 years of Cost of Revenue data on file, last reported at $83.6 million in Q2 2026.

• Quarterly Cost of Revenue fell 22.2% year-over-year to $83.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $348.2 million (down 60.09% YoY) and the FY2025 annual result came in at $400.9 million, down 18.94% from the prior year.
• Cost of Revenue advanced to $83.6 million in Q2 2026, from $78.4 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $395.7 million in Q3 2024 to a low of $78.4 million in Q1 2026.
• A 5-year average of $153.7 million and a median of $114.1 million in 2023 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2024 — Cost of Revenue surged 271.94% — and 2025, when it tumbled 74.28%.
• Tracing OPK's Cost of Revenue over 5 years: stood at $194.8 million in 2022, then advanced by 8.81% to $211.9 million in 2023, then jumped by 86.71% to $395.7 million in 2024, then slumped by 78.66% to $84.4 million in 2025, then retreated by 1.02% to $83.6 million in 2026.
• The last three Cost of Revenue figures came in at $83.6 million (Q2 2026), $78.4 million (Q1 2026), and $84.4 million (Q4 2025), per Business Quant data.